Belgium-Luxemburg

“ Prix Galien is an excellent opportunity to highlight once again the importance of research and development in the pharmaceutical world ”

-Maggie De BLOCK, Belgium Healthcare Minister – 2015

Contact: Isabelle Spettante

Committee

Winners - 2016

Dr De Bock Marijke, Dr Decrock Elke et Dr Wang Nan – Universiteit Gent

works on Connexin hemichannels as druggable targets for brain and cardiovascular disease

Nivolumab, (Opdivo BMS Belgium & Luxembourg)
Pembrolizumab (Keytruda MSD Belgium and Luxembourg)
S-ICD EMBLEM Boston Scientific

See all winners in our Hall of Fame

The Prix Galien Award is the biomedical industry's highest accolade, recognizing the development of the world’s most innovative medicines and devices.